| 0 | ℹ |
Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRAS(G12D) mutations: a phase 1 trial.
(nature.com)
|
Nature Medicine 2026-09-01 | #oncology #kras #clinical trial #pharmacokinetics #immunotherapy |